Tin Mesoporphyrin IX (chloride)
| 规格 | 价格 | 货期 | 数量 |
|---|---|---|---|
| 5mg | ¥1191.00 | 现货 | |
| 10mg | ¥2112.00 | 现货 | |
| 25mg | ¥3141.00 | 现货 |
特色产品
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
产品描述
Ki = 14 nM
Tin Mesoporphyrin IX is a potent and competitive inhibitor of heme oxygenase (HO) activity.
Heme oxygenase or haem oxygenase (HO) is an enzyme catalyzing the degradation of heme. This produces biliverdin, ferrous iron, and carbon monoxide. There is limited evidence that levels of heme oxygenase are positive predictors of metabolic disease, insulin resistance, and metaflammation.
In vitro: Previous study found that Tin Mesoporphyrin IX was a potent competitive in-vitro inhibitor of enzyme activity when it was incubated with rat splenic microsomal heme oxygenase, with a Ki of 0.014 microM [1].
In vivo: Animal study showed that Tin Mesoporphyrin IX at 1 pmol/kg body wt could inhibit hepatic, renal, and splenic heme oxygenase activity in adult animals for extended periods of time. Tin Mesoporphyrin IX at 1 pmol/kg body wt also prevented the transient increase in serum bilirubin 24 h after birth in the rat neonate and significantly reduced the levels of serum bilirubin in aminolevulinic acid induced hyperbilirubinemia in the 7-day-old suckling neonate. Moreover, it was found that the tissue heme oxygenase activity decreased in both animal models of hyperbilirubinemia. Tin Mesoporphyrin IX treatment resulted in a prolonged increase in the heme saturation of hepatic tryptophan pyrrolase [1].
Clinical trial: So far, no clinical study has been conducted.
Reference:
[1] Drummond, G. S.,Galbraith, R.A.,Sardana, M.K., et al. Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolism. Archives of Biochemistry and Biophysics 255(1), 64-74 (1987).
产品性质
| 物理外观 | A crystalline solid |
| CAS号 | 106344-20-1 |
| 分子式 | C34H34Cl2N4O4Sn·2H |
| 分子量 | 754.3 |
| 化学名称 | (OC-6-13)-dichloro[7,12-diethyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-κN21,κN22,κN23,κN24]-stannate(2-), dihydrogen |
| 溶解度 | ≤0.5mg/ml in DMSO;1mg/ml in dimethyl formamide |
| SMILES | [Cl-][Sn+4]123([N-]4C5=C(CCC([O-])=O)C(C)=C4C=C(C(CC)=C6C)[N]1=C6C=C(C(CC)=C7C)[N-]2C7=CC8=[N]3C(C(CCC([O-])=O)=C8C)=C5)[Cl-].[H+].[H+] |
| 存储条件 | -20°C |
| 运输条件 | 蓝冰 |
产品应用 (实验数据来自文献,APExBIO并未验证,仅供参考)
IC50和靶点
| 生物活性描述 | 二氯化锡(IV)间卟啉 IX(Stannsoporfin)是一种血红素加氧酶(HO)抑制剂,正在开发用于预防有黄疸风险的婴儿出现高胆红素血症。 |



沪公网安备 31011002003500